Carnegie Investment Counsel’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDN
RW
CIM
ACA
FFA
Carnegie Investment Counsel's IBDN Position: Q1 2019 in Review
Carnegie Investment Counsel sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q1 2019, closing a stake of 12,408 shares — an estimated $300K sold.
Carnegie Investment Counsel first reported a position in IBDN in Q4 2018 and held it in 1 quarter. The position peaked at $300K in Q4 2018. 124 funds tracked by Wall St. Rank hold IBDN as of Q1 2019.
- Carnegie Investment Counsel reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q1 2019 after selling out during the quarter.
- Carnegie Investment Counsel sold 12,408 iShares iBonds Dec 2022 Term Corporate ETF shares in Q1 2019, an estimated $300K.
- Carnegie Investment Counsel first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q4 2018 and held it in 1 quarter.
- Carnegie Investment Counsel's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $300K in Q4 2018.
- 124 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q1 2019.
Based on Carnegie Investment Counsel's 13F filing for Q1 2019, filed 14 May 2019.